Our Partners

Founded on collaboration in 1993, we believe strongly in advancing drug discovery and development for medicines that matter through scientific collaboration and business-to-business partnerships. Our collaborative approach forms a "shared R&D economy" for enhanced flexibility and efficiency. Find out about ongoing successful partnerships by exploring our Co-owned Pipeline and Partnership Spotlights.


Co-Owned Pipeline

Through co-owned partnerships, risk, cost and IP are shared within strategic R&D alliances. The aim of these partnerships is to develop R&D projects faster and more efficiently based on knowledge sharing.

Learn more

Partnership Spotlight

Explore the stories of innovation, breakthroughs, and mutual achievements that have emerged through our dynamic alliances with our partners across diverse domains.

Evotec Ventures

We aim to lower barriers to develop medicines that matter through both strategically investing in early-stage biotech and creating / supporting pre-seed incubators with academic institutions.


Academic BRIDGEs

The goal of evolution is not one single human, it is mankind."
Manfred Eigen, Co-founder of Evotec, Nobel Prize 1967
Claudia Karnbach

Claudia Karnbach

Global Head, EVP Partnering Excellence & Operations

Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.